Pacira Pharmaceuticals, Inc.【PCRX】 業績推移・財務諸表

(単位:千ドル) 2Q11 3Q11 1Q12 2Q12 3Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 3,636 3,956 7,804 12,344 8,486 11,587 17,141 23,259 33,564 36,662 47,165 52,048 61,793 58,316 59,148 62,213 69,320 65,474 69,640 68,355 72,902 69,283 70,934 67,335 79,078 74,607 84,107 83,448 95,115 91,313 102,604 104,685 122,424 105,684 75,505 117,484 130,974 119,027 135,590 127,722 157,991 169,411 167,466 160,341 169,467 163,926 167,117 178,023 168,573 168,923
売上成長率(%) - - - -
売上原価 3,115 3,357 6,495 6,685 9,287 11,391 10,214 14,791 18,376 18,127 19,954 20,391 18,968 17,580 18,929 15,901 19,427 20,278 23,053 43,152 23,621 24,581 23,811 18,228 21,295 22,885 20,916 19,065 23,979 27,303 25,201 22,304 31,904 29,732 22,305 29,993 35,298 31,349 35,248 34,651 36,074 50,627 50,678 49,020 48,207 39,750 47,416 44,262 38,864 34,306
研究開発費 4,381 4,344 1,294 1,872 3,527 5,905 4,857 5,962 - 5,204 5,216 4,425 - 5,967 3,649 5,893 - 9,493 9,362 9,754 - 16,632 18,856 11,775 - 14,378 12,239 14,897 - 14,384 17,827 20,255 - 15,819 13,620 14,651 - 15,879 12,573 11,578 21,605 26,282 19,405 17,140 18,824 20,830 18,238 20,338 19,104 25,342
販売管理費 4,671 4,988 11,152 10,413 11,378 12,936 14,080 15,320 - 22,589 24,837 28,217 - 31,428 34,752 35,310 - 37,957 43,669 36,314 - 42,120 39,552 40,644 - 44,191 44,249 44,179 - 48,518 49,126 50,128 - 44,780 43,342 52,561 - 48,522 50,813 48,807 64,260 65,003 61,283 70,843 64,850 67,947 72,026 68,126 74,333 86,776
営業費用 12,167 12,689 18,941 18,970 24,192 30,232 29,151 36,073 43,384 45,920 50,007 53,033 53,873 54,975 57,330 57,104 70,133 67,728 76,084 89,220 75,363 83,333 86,714 70,907 70,613 81,544 77,566 79,400 82,852 90,234 97,329 102,272 120,711 88,590 82,652 99,864 112,191 99,590 100,747 96,289 140,598 138,176 146,177 163,432 129,590 146,205 153,905 149,783 308,100 166,933
営業利益 -8,531 -8,733 -11,137 -6,626 -15,706 -18,645 -12,010 -12,814 - -9,258 -2,842 -985 - 3,341 1,818 5,109 - -2,254 -6,444 -20,865 - -14,050 -15,780 -3,572 - -6,937 6,541 4,048 - 1,079 5,275 2,413 - 17,094 -7,147 17,620 - 19,437 34,843 31,433 17,393 31,235 21,289 -3,091 39,877 17,721 13,212 28,240 -139,527 1,990
営業利益率 (%) - - - - - - - -
経常(税引前)利益 - - - - - -23,580 -14,031 -14,784 - -11,477 -5,037 -3,004 - 1,312 47 3,367 - -3,822 -7,900 -22,128 - -19,836 -19,713 -7,552 - -10,645 2,599 -702 - -2,518 1,127 -5,816 - 8,557 -7,311 6,150 - 12,724 25,648 24,231 7,294 22,007 2,069 -26,474 37,854 16,601 13,640 36,584 -138,856 8,706
経常(税引前)利益率(%) - - - - - -203.5 -81.86 -63.56 - -31.3 -10.68 -5.77 - 2.25 0.08 5.41 - -5.84 -11.34 -32.37 - -28.63 -27.79 -11.22 - -14.27 3.09 -0.84 - -2.76 1.1 -5.56 - 8.1 -9.68 5.23 - 10.69 18.92 18.97 4.62 12.99 1.24 -16.51 22.34 10.13 8.16 20.55 -82.37 5.15
法人税等合計 - - - - - -442 - 0 - 0 0 0 - 52 39 281 - 32 58 36 - 30 30 45 - 35 35 -62 - 253 -1,600 300 - 400 -42 -124,000 - 2,400 6,600 6,600 500 2,131 2,762 -6,938 12,091 5,743 4,661 17,698 4,610 3,894
実効税率(%) - - - - - - - - - - - - - -
純利益 -8,763 -9,508 -11,894 -8,296 -15,745 -23,138 -14,031 -14,784 -11,956 -11,477 -5,037 -3,004 5,802 1,260 8 3,086 -2,498 -3,854 -7,958 -22,164 -3,973 -19,866 -19,743 -7,597 4,595 -10,680 2,564 -640 8,285 -2,771 2,730 -6,087 -4,888 8,159 -7,269 130,119 14,514 10,369 19,081 17,660 6,828 19,876 -693 -19,536 25,763 10,858 8,979 18,886 -143,466 4,812
純利益率(%)
一株あたり利益 - - - - - - - - - - - - - - - 0.08 - - - -0.59 - - - - - - - - - - 0.07 - - - -0.17 3.03 0.33 0.24 0.43 0.4 0.15 0.44 -0.02 -0.43 0.56 0.23 0.19 0.41 -3.11 0.1
希薄化後一株あたり利益 - - - - - - - - - - - - - - - 0.08 - - - -0.59 - - - - - - - - - - 0.06 - - - -0.17 2.94 0.32 0.23 0.42 0.39 0.15 0.4 -0.02 -0.43 0.51 0.23 0.19 0.39 -3.11 0.1
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -